By Jade Martinez-Pogue ( June 29, 2023, 2:13 PM EDT) -- Pharmaceutical giant Eli Lilly & Co. on Thursday announced it has agreed to buy Cambridge, Massachusetts-based biopharmaceutical company Sigilon Therapeutics Inc. in a deal that could be worth upward of $300 million and was built by Morgan Lewis & Bockius LLP and Ropes & Gray LLP....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.